|
[1]
|
张曼, 刘雅, 孙伟民. 慢性阻塞性肺疾病发病机制研究进展[J]. 临床医学进展, 2021, 11(6): 2685-2688.
|
|
[2]
|
Jones, B., Donovan, C., Liu, G., Gomez, H.M., Chimankar, V., Harrison, C.L., et al. (2016) Animal Models of COPD: What Do They Tell Us? Respirology, 22, 21-32. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Gorska, K., Nejman-Gryz, P., Paplinska-Goryca, M., Korczynski, P., Prochorec-Sobieszek, M. and Krenke, R. (2018) Comparative Study of IL-33 and IL-6 Levels in Different Respiratory Samples in Mild-to-Moderate Asthma and COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease, 15, 36-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
徐珍, 梁姗姗, 刘甡, 鲍文华, 孙云晖. COPD患者血清中IL-37水平变化及临床意义[J]. 黑龙江医药科学, 2016, 39(3): 21-22.
|
|
[5]
|
Göpfert, C., Andreas, N., Weber, F., Häfner, N., Yakovleva, T., Gaestel, M., et al. (2018) The P38-Mk2/3 Module Is Critical for IL-33-Induced Signaling and Cytokine Production in Dendritic Cells. The Journal of Immunology, 200, 1198-1206. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
袁立燕, 谢杰, 薛汝增, 谷梅, 杨斌. 白细胞介素37的免疫学研究进展[J]. 皮肤性病诊疗学杂志, 2016, 23(4): 280-284.
|
|
[7]
|
Pavord, I.D., Lettis, S., Anzueto, A. and Barnes, N. (2016) Blood Eosinophil Count and Pneumonia Risk in Patients with Chronic Obstructive Pulmonary Disease: A Patient-Level Meta-Analysis. The Lancet Respiratory Medicine, 4, 731-741. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Adeloye, D., Song, P., Zhu, Y., Campbell, H., Sheikh, A. and Rudan, I. (2022) Global, Regional, and National Prevalence of, and Risk Factors for, Chronic Obstructive Pulmonary Disease (COPD) in 2019: A Systematic Review and Modelling Analysis. The Lancet Respiratory Medicine, 10, 447-458. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Fang, X., Wang, X. and Bai, C. (2011) COPD in China: The Burden and Importance of Proper Management. Chest, 139, 920-929. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
林玛丽, 蔡旭龙, 冯巍巍, 曹珊, 林娜, 刘运广. 白细胞介素-33在慢性呼吸系统疾病中的作用研究进展[J]. 广西医学, 2017, 39(7): 1053-1056.
|
|
[11]
|
牛莎. 血清因子与免疫因子对慢性阻塞性肺疾病患者肺功能与病情影响的研究[J]. 医学理论与实践, 2020, 33(23): 3886-3888.
|
|
[12]
|
Di Salvo, E., Ventura-Spagnolo, E., Casciaro, M., Navarra, M. and Gangemi, S. (2018) IL-33/IL-31 Axis: A Potential Inflammatory Pathway. Mediators of Inflammation, 2018, Article ID: 3858032. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Nakamura, N., Tamagawa-Mineoka, R., Yasuike, R., Masuda, K., Matsunaka, H., Murakami, Y., et al. (2019) Stratum Corneum Interleukin-33 Expressions Correlate with the Degree of Lichenification and Pruritus in Atopic Dermatitis Lesions. Clinical Immunology, 201, 1-3. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Duan, L., Chen, J., Zhang, H., Yang, H., Zhu, P., Xiong, A., et al. (2012) Interleukin-33 Ameliorates Experimental Colitis through Promoting Th2/foxp3+ Regulatory T-Cell Responses in Mice. Molecular Medicine, 18, 753-761. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Rudloff, I., Ung, H.K., Dowling, J.K., Mansell, A., D’Andrea, L., Ellisdon, A.M., et al. (2020) Parsing the IL-37-Mediated Suppression of Inflammasome Function. Cells, 9, Article No. 178. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
高胜男, 林江涛. IL-37的抗炎作用机制及其在哮喘中的研究进展[J]. 中华微生物学和免疫学杂志, 2021, 41(6): 488-492.
|
|
[17]
|
李慧敏, 罗红, 周湧. 慢性阻塞性肺疾病患者IL-37与IL-6, IL-17相关性研究[J]. 实用预防医学, 2020, 27(4): 506-508.
|
|
[18]
|
Ernst, O., Vayttaden, S.J. and Fraser, I.D.C. (2017) Measurement of NF-κB Activation in TLR-Activated Macrophages. In: De Nardo, D. and De Nardo, C.M., Eds., Innate Immune Activation: Methods and Protocols, Springer, Berlin, 67-78. [Google Scholar] [CrossRef] [PubMed]
|